Veterinary Tuberculosis Vaccine Market, By Type, By Route of Administration, By Animal Type, By Geography

Veterinary Tuberculosis Vaccine Market is estimated to be valued at USD 57 Mn in 2026 and is expected to reach USD 71 Mn by 2033, growing at a compound annual growth rate (CAGR) of 3.2% from 2026 to 2033.

Tuberculosis (TB) is considered a reemerging, infectious granulomatous disease in animals and people caused by acid-fast bacilli of the genus Mycobacterium. Although commonly considered as a chronic, debilitating disease, TB occasionally assumes an acute, rapidly progressive course. The disease affects practically all species of vertebrates. The widespread occurrence of multidrug-resistant (MDR) strains and extensively drug-resistant (XDR) strains of M tuberculosis is of concern to clinicians and public health and regulatory officials involved in the control of the disease. Bovine TB is still a significant zoonosis in non-industrialized countries of the world. Signs and lesions are generally similar in the various species. The main types of M tuberculosis complex (mammalian tubercle bacilli) recognized are M tuberculosis, M canettii, M bovis, M caprae, M pinnipedii, M microti, M mungi, and M africanum. The M avium complex includes M avium avium (avian tubercle bacilli), M avium hominissuis (isolated from people, swine, and other mammals), and M intracellular.

Market Dynamics

Increasing undergoing trial for vaccination is expected to fuel growth of the global veterinary tuberculosis vaccine market over the forecast period.

For instance, according to a report published by Multidisciplinary Digital Publishing Institute in June 2020, BCG (Danish) vaccine type is administered by intramuscular to badgers for the prevention of tuberculosis. According to the same source, heat-inactivated Mycobacterium bovis vaccine (HIMB) is administered by intramuscular method to goats for the prevention of tuberculosis

Furthermore, increasing awareness programs for veterinary tuberculosis by government authorities is expected to drive growth of the global veterinary tuberculosis vaccine market over the forecast period.

For instance, on November 16, 2021, The Welsh Government, U.K. announced the Tuberculosis (TB) Eradication Programme. This program's goal was to offer a TB testing programme in Wales, U.K., in order to further lower the danger of the spread of TB. The Welsh Government, U.K. has advised to make informed purchase selections and to disclose TB information about any cattle they seek to sell. Payments for animals that were killed due to TB, to make sure the method is just and appropriate and takes into account the available funding.

Key features of the study

• This report provides an in-depth analysis of the global veterinary tuberculosis vaccine market, and provides market size (US$ Million) and compound annual growth rate (CAGR%) for the forecast period (2022-2030), considering 2021 as the base year
• It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
• This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
• It profiles key players in the global veterinary tuberculosis vaccine market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies
• Key companies covered as a part of this study include Merck KGaA, Colorado Serum Company, CZ Vaccines (Zendal), and Zoetis Inc.
• Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
• The global veterinary tuberculosis vaccine market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
• Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global veterinary tuberculosis vaccine market

Market Segmentation

• By Type
  • Live Attenuated
  • Inactivated
• By Route of Administration
  • Sub-cutaneous
  • Intramuscular
  • Oral
• By Animal Type
  • Cattle
  • Dogs
  • Cats
  • Others
• By Region
  • North America
  • U.S.
  • Canada
  • Latin America
  • Brazil
  • Argentina
  • Mexico
  • Rest of Latin America
  • Europe
  • Germany
  • U.K.
  • Spain
  • France
  • Italy
  • Russia
  • Rest of Europe
  • Asia Pacific
  • China
  • India
  • Japan
  • Australia
  • South Korea
  • ASEAN
  • Rest of Asia Pacific
  • Middle East
  • GCC Countries
  • Israel
  • Rest of Middle East
  • Africa
  • South Africa
  • North Africa
  • Central Africa
• Key Players
  • Merck KGaA
  • Colorado Serum Company
  • CZ Vaccines (Zendal)
  • Zoetis Inc